All In MedTech

FDA Clearance Tracker · P100010-S001

ARCTIC FRONT CARDIAC CRYOABLATION SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 23, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 23, 2011

Approved

Time to decision

223 days

Received Jan 12, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100010-S001
Device name
ARCTIC FRONT CARDIAC CRYOABLATION SYSTEM
Applicant location
Mounds View, MN
Received
Jan 12, 2011
Decided
Aug 23, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P100010

Device type

Device class
Class III

Every decision under product code OAE

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Medtronic Cryocath, LP

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.